167 related articles for article (PubMed ID: 15491811)
1. Development of implant tablet for a week-long sustained release.
Takahashi M; Onishi H; Machida Y
J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
[TBL] [Abstract][Full Text] [Related]
2. PLGA implant tablet of ketoprofen: comparison of in vitro and in vivo releases.
Onishi H; Takahashi M; Machida Y
Biol Pharm Bull; 2005 Oct; 28(10):2011-5. PubMed ID: 16204968
[TBL] [Abstract][Full Text] [Related]
3. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
4. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
6. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
[TBL] [Abstract][Full Text] [Related]
8. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
9. Controlled-release implant system formulated using biodegradable hemostatic gauze as scaffold.
Xu L; Wu F; Yuan W; Jin T
Int J Pharm; 2008 May; 355(1-2):249-58. PubMed ID: 18249510
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
[TBL] [Abstract][Full Text] [Related]
11. How to achieve sustained and complete protein release from PLGA-based microparticles?
Giteau A; Venier-Julienne MC; Aubert-Pouëssel A; Benoit JP
Int J Pharm; 2008 Feb; 350(1-2):14-26. PubMed ID: 18162341
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
13. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
14. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
15. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer.
Santoveña A; Fariña JB; Llabrés M; Zhu Y; Dannies P
Int J Pharm; 2010 Mar; 388(1-2):175-80. PubMed ID: 20060456
[TBL] [Abstract][Full Text] [Related]
17. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Yin J; Noda Y; Yotsuyanagi T
Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
[TBL] [Abstract][Full Text] [Related]
19. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
20. Utilization of poly(DL-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression.
Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
J Control Release; 2000 Jun; 67(1):29-36. PubMed ID: 10773326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
